HCC

>

Latest News

Hope Beyond Surgery: Optimizing Care for Cholangiocarcinoma
Hope Beyond Surgery: Optimizing Care for Cholangiocarcinoma

February 15th 2024

In an interview for Cholangiocarcinoma Awareness Day, Domenech Asbun, MD, discussed how the management of cholangiocarcinoma continues to evolve and addressed unmet needs in early detection and systemic therapy.

Durvalumab/Bevacizumab/TACE Significantly Extends Survival in HCC
Durvalumab/Bevacizumab/TACE Significantly Extends Survival in HCC

February 6th 2024

FDA Fast Tracks BST02 for Liver Cancer
FDA Fast Tracks BST02 for Liver Cancer

February 2nd 2024

Regorafenib Discontinuation More Likely With Poor Liver Function in Liver Cancer
Regorafenib Discontinuation More Likely With Poor Liver Function in Liver Cancer

January 19th 2024

Fostrox Plus Lenvatinib Appears Safe, Tolerable in Second- and Third-Line HCC
Fostrox Plus Lenvatinib Appears Safe, Tolerable in Second- and Third-Line HCC

January 19th 2024

Video Series
Video Interviews
Podcasts

More News